Tag : new generation sequencing

Collaboration will provide biopharmaceutical companies access to Guardant Health’s broad portfolio of cancer tests to help advance drug development programs and their clinical trials Guardant...

New Lab Opening Brings Expanded Capabilities to European Clients 3000sqft Sampled SMART Lab expansion based in UK New capabilities for European clients focused on biosample...

The global next-generation sequencing market size is expected to reach USD 14.8 billion by 2030, registering a CAGR of 12.4% over the forecast period, according to a new report...

– Esteemed cancer researcher and co-founder of GV20 Shirley Liu appointed as Chief Executive Officer – Drug development leaders Steven Landau and Ying Gong named to executive roles...

Sequential Skin Ltd, a leading skin genomics start-up, has been awarded an Innovate UK SMART Grant to fund a project on advancing current understanding of the skin...

Investment from LifeArc, Illumina, and Illumina Ventures will fund genomics startups for Illumina Accelerator Cambridge graduates Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing...

ERS Genomics Limited (‘ERS’) is pleased to announce a new license agreement with Cytosurge AG (“Cytosurge”). This is a non-exclusive licensing agreement granting Cytosurge access...

BGI Group continues to lead in life sciences, making breakthroughs from single cell technology to spatiotemporal genomics, 22 years after participating in the Human Genome...

CosmosID®, a leading microbial genomics company focused on standardized, high-resolution microbiome analysis, and Locus Biosciences, Inc. (“Locus”), a clinical-stage biotechnology company developing a new class...

The oversubscribed series B financing led by Healthcare Venture Partners, added SoftBank Corp. and Natera to existing investors– Sequoia Capital, Foresite Capital, Founders Fund, among...